SCHEMBL6578298

SCHEMBL6578298

Cc1ccc2cccc(OCc3c(Cl)ccc(S(=O)(=O)N(C)C(C)(C)C)c3Cl)c2n1

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 20/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6576101 0.89 BDKRB2 (0.51) BDKRB2
SCHEMBL7802922 0.85 BDKRB2 (0.59) BDKRB2
SCHEMBL7807570 0.85 BDKRB2 (0.61) BDKRB2
SCHEMBL4058616 0.85 BDKRB2 (0.65) BDKRB2
SCHEMBL7807760 0.85 BDKRB2 (0.65) BDKRB2
SCHEMBL7815163 0.84 BDKRB2 (0.63) BDKRB2
SCHEMBL7812078 0.83 BDKRB2 (0.59) BDKRB2
SCHEMBL7809422 0.83 BDKRB2 (0.58) BDKRB2
SCHEMBL7803014 0.83 BDKRB2 (0.73) BDKRB2
Hydrochloric Acid SCHEMBL8480000 0.83 BDKRB2 (0.62) BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0867432-B1 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists AVENTIS PHARMA GMBH (DE) 2004-06-09 EP disclosed
EP-0773932-B1 BENZENESULFONAMIDE DERIVATIVES USED AS BRADYKININE ANTAGONISTS FOURNIER IND & SANTE (FR) 2001-09-26 EP disclosed
US-6211196-B1 8-BENZYLOXY-(TETRAHYDRO)QUINOLINE DERIVATIVES; LIVER CIRRHOSIS, ALZHEIMER*S DISEASE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-04-03 US disclosed
US-5968951-A Benzenesulfonamide derivatives as bradykinin antagonists FOURNIER INDUSTRIE ET SANTE (FR) 1999-10-19 US disclosed
EP-0867432-A2 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists HOECHST AKTIENGESELLSCHAFT (DE) 1998-09-30 EP disclosed